These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9778228

  • 1. Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis.
    Stolk JN, Boerbooms AM, de Abreu RA, de Koning DG, van Beusekom HJ, Muller WH, van de Putte LB.
    Arthritis Rheum; 1998 Oct; 41(10):1858-66. PubMed ID: 9778228
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A, Ghandi N, Hallaji Z, Chams-Davatchi C, Valikhani M, Karbakhsh Davari M.
    Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
    [Abstract] [Full Text] [Related]

  • 5. Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis.
    Kerstens PJ, Stolk JN, De Abreu RA, Lambooy LH, van de Putte LB, Boerbooms AA.
    Arthritis Rheum; 1995 Jan; 38(1):142-5. PubMed ID: 7818564
    [Abstract] [Full Text] [Related]

  • 6. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP, Luna M, Maté J, González-Guijarro L, Cara C, Pajares JM.
    Hepatogastroenterology; 2006 Jan; 53(69):399-404. PubMed ID: 16795981
    [Abstract] [Full Text] [Related]

  • 7. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
    Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T.
    J Gastroenterol; 2003 Jan; 38(8):740-6. PubMed ID: 14505127
    [Abstract] [Full Text] [Related]

  • 8. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
    Roblin X, Peyrin-Biroulet L, Phelip JM, Nancey S, Flourie B.
    Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961
    [Abstract] [Full Text] [Related]

  • 9. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
    Snow JL, Gibson LE.
    Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.
    Clunie GP, Lennard L.
    Rheumatology (Oxford); 2004 Jan; 43(1):13-8. PubMed ID: 14566029
    [Abstract] [Full Text] [Related]

  • 12. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
    Fargher EA, Tricker K, Newman W, Elliott R, Roberts SA, Shaffer JL, Bruce I, Payne K.
    J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
    [Abstract] [Full Text] [Related]

  • 13. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q, Zhu Q, Shang Y, Gao M, Si J.
    Digestion; 2009 Apr; 79(1):58-63. PubMed ID: 19252404
    [Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.
    Ansari A, Arenas M, Greenfield SM, Morris D, Lindsay J, Gilshenan K, Smith M, Lewis C, Marinaki A, Duley J, Sanderson J.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):973-83. PubMed ID: 18616518
    [Abstract] [Full Text] [Related]

  • 15. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.
    Marra CA, Esdaile JM, Anis AH.
    J Rheumatol; 2002 Dec 15; 29(12):2507-12. PubMed ID: 12465143
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
    Sanderson J, Ansari A, Marinaki T, Duley J.
    Ann Clin Biochem; 2004 Jul 15; 41(Pt 4):294-302. PubMed ID: 15298741
    [Abstract] [Full Text] [Related]

  • 18. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
    Winter JW, Gaffney D, Shapiro D, Spooner RJ, Marinaki AM, Sanderson JD, Mills PR.
    Aliment Pharmacol Ther; 2007 May 01; 25(9):1069-77. PubMed ID: 17439508
    [Abstract] [Full Text] [Related]

  • 19. Thiopurine S-methyltransferase genotypic analysis in autoimmune bullous diseases.
    Bezier M, Reguiai Z, Vitry F, Broly F, Bernard P.
    Eur J Dermatol; 2008 May 01; 18(5):512-7. PubMed ID: 18693152
    [Abstract] [Full Text] [Related]

  • 20. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
    Song DK, Zhao J, Zhang LR.
    J Clin Pharm Ther; 2006 Dec 01; 31(6):627-35. PubMed ID: 17176368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.